Establishing a Registry for Post-COVID-19 Vaccination Syndromes and Comprehensive Analysis of COVID-19 Vaccine-Related Outcomes
Not Applicable
- Conditions
- Post-COVID-19 vaccination syndromes
- Registration Number
- JPRN-UMIN000053578
- Lead Sponsor
- Japanese Society for Vaccine-related Complications
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint of the study is the characterization of adverse events that are definitely or almost certainly related to the novel coronavirus vaccine.
- Secondary Outcome Measures
Name Time Method - Occurrence or non-occurrence of Grade3 or above adverse events - Presence or absence of adverse events(adverse reactions) for which acausal relationship could not be ruled out - Time to onset of adverse events, Grade3 or above adverse events and adverse reactions